https://charts.traderzeitung.de/phases/US48115J1097 string(1399) "{"isin":"US48115J1097","name":"Journey Medical Corp","stock_id_xnas":20032457,"stock_id_xnys":null,"generated_at":"2026-09-24 01:32:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":6.975,"close_at":"2026-09-21 21:58:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":7.29,"close_at":"2026-09-22 21:57:00","complete":true,"perf_pct":4.5161},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":6.505,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-10.7682},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"

Journey Medical Aktie News & Nachrichten

[WKN: A3C7KG | Symbol: DERM]

Realtimekurs

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Journey Medical gefunden werden.

Journey Medical Nachrichtenticker öffnen

MT Newswires 13.08.2026 14:10 Uhr

--B. Riley passt Kursziel für Journey Medical von $12 auf $15 an, belässt Buy-Rating

08:09 AM EDT, 13.08.2026 (MT Newswires) -- Journey Medical (DERM) hat laut von FactSet befragten Analysten ein durchschnittliches Rating von Buy und e